Bio-Rad Laboratories, Inc. Class A Common Stock vs PAGSEG Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while PAGSEG Inc trades at $8.79 (market cap $2.48B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 3.8× PAGSEG Inc's market cap, and PAGSEG Inc pays a 11.7% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | PAGS | |
|---|---|---|
Market Cap | $9.43B | $2.48B |
Sector | Health | Technology |
52-Week High | $356.25 | $12.00 |
52-Week Low | $241.71 | $8.38 |
Enterprise Value | $9.18B | $10.22B |
Dividend Yield | — | 11.7% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →